Compare Amylx Pharmaceuticals Inc (AMLX) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs United States Natural Gas Fund — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while United States Natural Gas Fund trades at $10.2. The key difference: Amylx Pharmaceuticals Inc is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.
| AMLX | UNG | |
|---|---|---|
Market Cap | $2.64B | — |
Sector | Health | Commodities - Energy |
52-Week High | $24.19 | $16.90 |
52-Week Low | $7.82 | $9.63 |
Enterprise Value | $2.39B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
